| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the Departments of Medicine, Surgery, and Transplantation, The University of North Carolina at Chapel Hill
Study objective: Osteoporosis and/or fractures have been reported as a complication of kidney, heart, liver, bone marrow, and, most recently, lung transplantation (LTx). We measured bone mineral density (BMD) before and after LTx to determine the frequency and severity of preoperative and postoperative osteoporosis.
Patients and methods: We conducted a cross-sectional study of BMD in 100 patients with various diagnoses before (n=55) and after (n=45) LTx.
Results: Age-matched mean spine and femoral BMDs were severely depressed before and after LTx placing 45% of the pre-LTx and 73% of the post-LTx patients at or below the fracture threshold (2 SDs below the mean). As expected, patients with cystic fibrosis had lower (p<0.05) mean spine and femoral BMD than patients with COPD or other lung diseases both before and after LTx. Nevertheless, considerable osteoporosis was present in the patients with COPD and other lung diseases before and after LTx. The best predictors of pre- and post-LTx Z scores were body mass index (r=0.56 to 0.59, p<0.001) and cumulative steroid dose/per kilogram (r=0.49-0.51, p< 0.001), respectively. Osteoporosis has resulted in 3 symptomatic fractures before and 12 after LTx.
Conclusions: Osteoporosis appears to be widespread in patients with end-stage respiratory failure before LTx and LTx, while often life-saving, has an adverse impact on BMD. As patients live longer after LTx, osteoporosis-related fractures may compromise quality of life by causing pain and debilitation.
Key Words: bone mineral density • fractures • lung transplantation • osteoporosis • steroids
Submitted on September 15, 1995
Accepted on December 22, 2007
This article has been cited by other articles:
|
|
 |
|
  O. Tschopp, C. Schmid, R. Speich, B. Seifert, E. W. Russi, and A. Boehler Pretransplantation bone disease in patients with primary pulmonary hypertension. Chest, April 1, 2006; 129(4): 1002 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Caplan-Shaw, S. M. Arcasoy, E. Shane, D. J. Lederer, J. S. Wilt, M. K. O'Shea, V. Addesso, J. R. Sonett, and S. M. Kawut Osteoporosis in Diffuse Parenchymal Lung Disease Chest, January 1, 2006; 129(1): 140 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. M. Maalouf and E. Shane Osteoporosis after Solid Organ Transplantation J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2456 - 2465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Aris, P. A. Merkel, L. K. Bachrach, D. S. Borowitz, M. P. Boyle, S. L. Elkin, T. A. Guise, D. S. Hardin, C. S. Haworth, M. F. Holick, et al. Guide to Bone Health and Disease in Cystic Fibrosis J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1888 - 1896. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S P Conway, B Oldroyd, A Morton, J G Truscott, and D G Peckham Effect of oral bisphosphonates on bone mineral density and body composition in adult patients with cystic fibrosis: a pilot study Thorax, August 1, 2004; 59(8): 699 - 703. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Gronowitz, D. Mellstrom, and B. Strandvik Normal Annual Increase of Bone Mineral Density During Two Years in Patients With Cystic Fibrosis Pediatrics, August 1, 2004; 114(2): 435 - 442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Levine A Survey of Clinical Practice of Lung Transplantation in North America Chest, April 1, 2004; 125(4): 1224 - 1238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Aris, G. E. Lester, M. Caminiti, A. D. Blackwood, M. Hensler, R. K. Lark, T. M. Hecker, J. B. Renner, U. Guillen, S. A. Brown, et al. Efficacy of Alendronate in Adults with Cystic Fibrosis with Low Bone Density Am. J. Respir. Crit. Care Med., January 1, 2004; 169(1): 77 - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.A. Ionescu and E. Schoon Osteoporosis in chronic obstructive pulmonary disease Eur. Respir. J., November 2, 2003; 22(46_suppl): 64S - 75s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.R. Glanville and M. Estenne Indications, patient selection and timing of referral for lung transplantation Eur. Respir. J., November 1, 2003; 22(5): 845 - 852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Katsura and K. Kida A Comparison of Bone Mineral Density in Elderly Female Patients With COPD and Bronchial Asthma Chest, December 1, 2002; 122(6): 1949 - 1955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. ARIS, J. C. ROUTH, J. J. LIPUMA, D. G. HEATH, and P. H. GILLIGAN Lung Transplantation for Cystic Fibrosis Patients with Burkholderia cepacia Complex . Survival Linked to Genomovar Type Am. J. Respir. Crit. Care Med., December 1, 2001; 164(11): 2102 - 2106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. GROTZ, C. NAGEL, D. POESCHEL, M. CYBULLA, K.-G. PETERSEN, M. UHL, C. STREY, G. KIRSTE, M. OLSCHEWSKI, A. REICHELT, et al. Effect of Ibandronate on Bone Loss and Renal Function after Kidney Transplantation J. Am. Soc. Nephrol., July 1, 2001; 12(7): 1530 - 1537. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K Lark, G. E Lester, D. A Ontjes, A. D Blackwood, B. W Hollis, M. M Hensler, and R. M Aris Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients Am. J. Clinical Nutrition, March 1, 2001; 73(3): 602 - 606. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. ARIS, G. E. LESTER, J. B. RENNER, A. WINDERS, A. DENENE BLACKWOOD, R. K. LARK, and D. A. ONTJES Efficacy of Pamidronate for Osteoporosis in Patients with Cystic Fibrosis following Lung Transplantation Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 941 - 946. [Abstract] [Full Text]
|
|
|
|
|
|
C. S. Haworth, A. K. Webb, J. J. Egan, P. L. Selby, P. S. Hasleton, P. W. Bishop, and T. J. Freemont Bone Histomorphometry in Adult Patients With Cystic Fibrosis Chest, August 1, 2000; 118(2): 434 - 439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Spira, C. Gutierrez, C. Chaparro, M. A. Hutcheon, and C. K.N. Chan Osteoporosis and Lung Transplantation: A Prospective Study Chest, February 1, 2000; 117(2): 476 - 481. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E M Laursen, C Mølgaard, K F Michaelsen, C Koch, and J Müller Bone mineral status in 134 patients with cystic fibrosis Arch. Dis. Child., September 1, 1999; 81(3): 235 - 240. [Abstract] [Full Text]
|
|
|
|
|
|
J. W. K. van den Berg, E. J. van der Jagt, G. H. Koeter, and W. Van der Bij Multiple Nodular Opacities on Chest Radiograph After Lung Transplantation Chest, January 1, 1999; 115(1): 272 - 274. [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Egan, F. C. Detterbeck, M. R. Mill, K. K. Gott, J. B. Rea, J. McSweeney, R. M. Aris, and L. J. Paradowski Lung transplantation for cystic fibrosis: effective and durable therapy in a high-risk group Ann. Thorac. Surg., August 1, 1998; 66(2): 337 - 346. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
International Guidelines for the Selection of Lung Transplant Candidates Am. J. Respir. Crit. Care Med., July 1, 1998; 158(1): 335 - 339. [Full Text] [PDF]
|
|
|
|
|
|
D. S. DONOVAN Jr., A. PAPADOPOULOS, R. B. STARON, V. ADDESSO, L. SCHULMAN, C. MCGREGOR, F. COSMAN, R. L. LINDSAY, and E. SHANE Bone Mass and Vitamin D Deficiency in Adults with Advanced Cystic Fibrosis Lung Disease Am. J. Respir. Crit. Care Med., June 1, 1998; 157(6): 1892 - 1899. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
